Cardinal Health SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 5, 2026, 6:47 a.m. ETView on SEC.gov Our explainer
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCardinal Health Q1 FY27 non-GAAP EPS of $3.26 Beats $2.94 Consensus; Raises FY27 Guidance to $12.80-$13.00
8-KOct. 1, 2026, 6:52 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCardinal Health signs binding letter of intent to extend CVS Health distribution agreements through June 2032 and reaffirms FY2027 EPS guidance of $12.40 to $12.60
8-KAug. 11, 2026, 6:47 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 11, 2026, 6:38 a.m. ETView on SEC.gov
Entry into a material definitive agreement · Termination of a material definitive agreement · Creation of a direct financial obligation · Financial statements and exhibits
8-KAug. 5, 2026, 6:39 a.m. ETView on SEC.gov
Departure/appointment of directors or officers